OMNISCIENT NEUROTECHNOLOGY EUROPE LIMITED

Omniscient Neurotechnology Europe Limited is a pioneering digital‑health company that creates personalised brain‑mapping solutions through advanced connectomics. By harnessing artificial‑intelligence algorithms and cloud‑based processing, the firm transforms raw MRI scans into a detailed digital map of an individual’s brain networks – the so‑called connectome – which can be accessed instantly by clinicians and scientists.

The company’s flagship platform, Quicktome, delivers two core services. For neurosurgeons it provides precise, patient‑specific network data that informs surgical planning, helping to maximise tumour resection while preserving critical function. For researchers it offers high‑throughput analysis of structural and functional neural data, generating insights that accelerate studies into conditions such as depression, Alzheimer’s disease, schizophrenia and stroke. Omniscient’s work is underpinned by a strong R&D team, multiple patents issued by the USPTO, and a growing portfolio of publications and citations.

With a mission to improve the lives of billions through precision brain medicine, Omniscient Neurotechnology Europe equips today’s pioneers in neurosurgery, psychology and neuroscience with the tools needed to unlock the brain’s plasticity and drive breakthrough care.